Cited by 118Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease: Rationale and Current Evidence

Tobinick, Edward·2009·CNS Drugs

DOI 10.2165/11310810-000000000-00000

Open this paper in CoChat — free account

Abstract

Tumour necrosis factor (TNF), a key regulator of varied physiological mechanisms in multiple organ systems, is an immune signalling molecule produced by glia, neurons, macrophages and other immune cells. In the brain, among other functions, TNF serves as a gliotransmitter, secreted by glial cells that envelope and surround synapses, which regulates synaptic communication between neurons. The role of TNF as a gliotransmitter may help explain the profound synaptic effects of TNF that have been demonstrated in the hippocampus, in the spinal cord and in a variety of experimental models. Excess TNF is present in the CSF of individuals with Alzheimer's disease (AD), and has been implicated as a mediator of the synaptic dysfunction that is hypothesized to play a central role in the pathogenesis of AD. TNF may also play a role in endothelial and microvascular dysfunction in AD, and in amyloidogenesis and amyloid-induced memory dysfunction in AD. Genetic and epidemiological evidence has implicated increased TNF production as a risk factor for AD. Perispinal administration of etanercept, a potent anti-TNF fusion protein, produced sustained clinical improvement in a 6-month, open-label pilot study in patients with AD ranging from mild to severe. Subsequent case studies have documented rapid clinical improvement following perispinal etanercept in both AD and primary progressive aphasia, providing evidence of rapidly reversible, TNF-dependent, pathophysiological mechanisms in AD and related disorders. Perispinal etanercept for AD merits further study in randomized clinical trials.

Integrity signals

Registry

Crossref · 10.2165/11310810-000000000-00000

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Activity-dependent scaling of quantal amplitude in neocortical neurons
Turrigiano, G. G., Leslie, K. R., Desai, N. S., Rutherford, L. C., & Nelson, S. B. (1998) · Nature · doi:10.1038/36103 · Cited by 2,226
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES
Batson, O. V. (1940) · Annals of Surgery · doi:10.1097/00000658-194007000-00016 · Cited by 1,930

Show all 115 references

Research works printed but not linked: 8

Chiarini, 2006, Ital J Anat Embryol, 111, 221
Tobinick, 2008, Medscape J Med, 10, 135
Bohac, 2002, Neurobiol Aging, 23, S1
Tobinick, 2006, MedGenMed, 8, 53
Batson, 1957, Am J Roentgenol, 78, 195
Tobinick, 2003, Swiss Med Wkly, 133, 170
Tobinick, 2006, MedGenMed, 8, 25
Baldo, 1998, Neuropsychology, 12, 259, 10.1037/0894-4105.12.2.259 · DOI · Paper page

Sorted by citations

Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
Glial contributions to neurodegeneration in tauopathies
Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409
RETRACTED: Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Rauf, A., Badoni, H., Abu‐Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S. (2022) · Molecules · doi:10.3390/molecules27103194 · Cited by 316
Retracted
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 276
TNFα in synaptic function: switching gears
Santello, M., & Volterra, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.001 · Cited by 253
The role of cytokines in modulating learning and memory and brain plasticity
Bourgognon, J.-M., & Cavanagh, J. (2020) · Brain and Neuroscience Advances · doi:10.1177/2398212820979802 · Cited by 262
Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling
Wang, Z., Liu, D., Wang, F., Liu, S., Zhao, S., Ling, E.-A., & Hao, A. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511002868 · Cited by 239
The roles of TNF in brain dysfunction and disease
Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 239
The common inflammatory etiology of depression and cognitive impairment: a therapeutic target
Allison, D. J., & Ditor, D. S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0151-1 · Cited by 245
TNFα Is Required for Late BRB Breakdown in Diabetic Retinopathy, and Its Inhibition Prevents Leukostasis and Protects Vessels and Neurons from Apoptosis
Hu, H., Gandhi, J. K., Zhong, X., Wei, Y., Gong, J., Duh, E. J., & Vinores, S. A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5768 · Cited by 217
Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
Tweedie, D., Ferguson, R. A., Fishman, K., Frankola, K. A., van Praag, H., Holloway, H. W., Luo, W., Li, Y., Caracciolo, L., Russo, I., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-106 · Cited by 208
Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
King, E., O'Brien, J. T., Donaghy, P. C., Morris, C. M., Barnett, N. A., Olsen, K., Martin-Ruiz, C. M., Taylor, J., & Thomas, A. J. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317134 · Cited by 187
Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death
Rossi, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.003 · Cited by 185
Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?
Leal, M. C., Casabona, J. C., Puntel, M., & Pitossi, F. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00053 · Cited by 181
Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway
Ramesh, V., Nair, D., Zhang, S. X. L., Hakim, F., Kaushal, N., Kayali, F. M., Wang, Y., Li, R. C., Carreras, A., & Gozal, D. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-91 · Cited by 166
APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective
Tai, L. M., Ghura, S., Koster, K. P., Liakaite, V., Maienschein‐Cline, M., Kanabar, P., Collins, N., Ben‐Aissa, M., Lei, A. Z., Bahroos, N., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13072 · Cited by 165
Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice
Jiang, Y., Li, K., Li, X., Xu, L., & Yang, Z. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109452 · Cited by 154
Reactive astrocytes give neurons less support: implications for Alzheimer's disease
Steele, M. L., & Robinson, S. R. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.018 · Cited by 145
A New Venue of TNF Targeting
Steeland, S., Libert, C., & Vandenbroucke, R. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051442 · Cited by 145
Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity
Wilkaniec, A., Gąssowska-Dobrowolska, M., Strawski, M., Adamczyk, A., & Czapski, G. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1027-y · Cited by 133
Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury
Tobinick, E. L., Kim, N. M., Reyzin, G., Rodriguez-Romanacce, H., & DePuy, V. (2012) · CNS Drugs · doi:10.1007/s40263-012-0013-2 · Cited by 132
Self-citation
Targeting TNF: a therapeutic strategy for Alzheimer's disease
Cheng, X., Shen, Y., & Li, R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.029 · Cited by 129
Methemoglobin Is an Endogenous Toll-Like Receptor 4 Ligand—Relevance to Subarachnoid Hemorrhage
Kwon, M. C., Woo, S., Kurland, D. B., Yoon, S. H., Palmer, A. F., Banerjee, U., Iqbal, S., Ivanova, S., Gerzanich, V., & Simard, J. M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035028 · Cited by 123
Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease
Steeland, S., Gorlé, N., Vandendriessche, C., Balusu, S., Brkić, M., Cauwenberghe, C. V., Imschoot, G. V., Wonterghem, E. V., Rycke, R. M. D., Kremer, A., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708300 · Cited by 125
Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease
Chang, R., Knox, J., Chang, J. H., Derbedrossian, A., Vasilevko, V., Cribbs, D. H., Boado, R. J., Pardridge, W. M., & Sumbria, R. K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00200 · Cited by 116
Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept
Page, S. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0057-y · Cited by 112
Astrocytes in Alzheimer's Disease: Emerging Roles in Calcium Dysregulation and Synaptic Plasticity
Vincent, A. J., Gasperini, R., Foa, L. C., & Small, D. H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101089 · Cited by 106
Inflammation, Cytokines, Immune Response, Apolipoprotein E, Cholesterol, and Oxidative Stress in Alzheimer Disease: Therapeutic Implications
Candore, G., Bulati, M., Caruso, C., Castiglia, L., Colonna‐Romano, G., Bona, D. D., Duro, G., Lio, D., Matranga, D., Pellicanò, M., et al. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0993 · Cited by 95
MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
Han, D., Dong, X., Zheng, D., & Nao, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01555 · Cited by 90
Exploring Biomarkers for Alzheimer’s Disease
Sharma, N. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/18828.8166 · Cited by 91
Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders
Winstone, J. K., Pathak, K. V., Winslow, W., Piras, I. S., White, J., Sharma, R., Huentelman, M. J., Pirrotte, P., & Velázquez, R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02544-5 · Cited by 89
Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice
Paouri, E., Tzara, O., Kartalou, G.-I., Zenelak, S., & Georgopoulos, S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2484-16.2017 · Cited by 76
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 76
The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis
Azizi, G., & Mirshafiey, A. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.705292 · Cited by 75
Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
Bhat, N. R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06978.x · Cited by 71
How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis?
Jones-Odeh, E., & Hammond, C. J. (2015) · Eye · doi:10.1038/eye.2015.158 · Cited by 70
Laser-captured microglia in the Alzheimer's and Parkinson's brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer's brain
Mastroeni, D., Nolz, J., Sekar, S., Delvaux, E., Serrano, G. E., Cuyugan, L., Liang, W. S., Beach, T. G., Rogers, J., & Coleman, P. D. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.019 · Cited by 67
Perispinal etanercept: a new therapeutic paradigm in neurology
Tobinick, E. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.52 · Cited by 64
Self-citation
Alzheimer’s Disease: Exploring the Role of Inflammation and Implications for Treatment
McCaulley, M. E., & Grush, K. A. (2015) · International Journal of Alzheimer s Disease · doi:10.1155/2015/515248 · Cited by 62
Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer’s disease cell and mouse models for neuroprotection and cognitive improvement
Chiu, Y., Lin, C., Lee, M.-C., Hsieh‐Li, H. M., Chen, C., Wu, Y., Chang, K., & Lee‐Chen, G. (2021) · Aging · doi:10.18632/aging.203125 · Cited by 61
Prevention of the β-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures
Couturier, J., Paccalin, M., Morel, M., Terro, F., Milin, S., Pontcharraud, R., Fauconneau, B., & Page, G. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-72 · Cited by 65
Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer’s Disease
Paouri, E., Tzara, O., Zenelak, S., & Georgopoulos, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170065 · Cited by 61
Rapid Improvement of Chronic Stroke Deficits after Perispinal Etanercept
Tobinick, E. L. (2011) · CNS Drugs · doi:10.2165/11588400-000000000-00000 · Cited by 58
Self-citation
Genotype–phenotype interactions in pediatric obstructive sleep apnea
Gozal, D., & Gozal, D. (2013) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2013.03.016 · Cited by 57
The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD‐L1 levels on CNS cells
Pittet, C. L., Newcombe, J., Antel, J. P., & Arbour, N. (2011) · Glia · doi:10.1002/glia.21158 · Cited by 56
Astrocyte signaling and neurodegeneration
Brambilla, L., Martorana, F., & Rossi, D. (2013) · Prion · doi:10.4161/pri.22512 · Cited by 58
Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
Agarwal, M., Alam, R., Haider, M. K., Malik, M. Z., & Kim, D.-K. (2020) · Nanomaterials · doi:10.3390/nano11010059 · Cited by 59
Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease
Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143156 · Cited by 52
Immediate Neurological Recovery Following Perispinal Etanercept Years After Brain Injury
Tobinick, E. L., Rodriguez-Romanacce, H., Levine, A., Ignatowski, T. A., & Spengler, R. N. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0186-1 · Cited by 47
Self-citation
Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs
Sood, A., & Raji, M. A. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05372-1 · Cited by 49
Magnesium Ions Inhibit the Expression of Tumor Necrosis Factor α and the Activity of γ-Secretase in a β-Amyloid Protein-Dependent Mechanism in APP/PS1 Transgenic Mice
Yu, X., Guan, P.-P., Zhu, D., Liang, Y.-Y., Wang, T., Wang, Z., & Wang, P. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00172 · Cited by 45
Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α‐synuclein, amyloid‐β and insulin resistance in neurodegenerative diseases
Clark, I. A., & Vissel, B. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14471 · Cited by 42
Inflammation: A Major Target for Compounds to Control Alzheimer’s Disease
Maccioni, R. B., Navarrete, L. P., González, A., González-Canacer, A., Guzmán‐Martínez, L., & Cortés, N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191014 · Cited by 42
Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence
Ignatowski, T. A., Spengler, R. N., Dhandapani, K. M., Folkersma, H., Butterworth, R. F., & Tobinick, E. L. (2014) · CNS Drugs · doi:10.1007/s40263-014-0174-2 · Cited by 41
Self-citation
Effects of vitamin E on neurodegenerative diseases: an update
İçer, M. A., Arslan, N., & Karadağ, M. G. (2021) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2021-003 · Cited by 44
Vaccination against Alzheimer disease
Fettelschoss‐Gabriel, A., Zabel, F., & Bachmann, M. F. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28183 · Cited by 39
Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage
Blackburn, S., Kumar, P. T., McBride, D. W., Zeineddine, H. A., Leclerc, J. L., Choi, H. A., Dash, P. K., Grotta, J. C., Aronowski, J. A., Cardenas, J. C., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00592 · Cited by 39
Nanotechnology approaches for enhanced CNS delivery in treating Alzheimer's disease
Arya, M. A., Kumar, M. K. M., Sabitha, M., Menon, K. N., & Nair, S. C. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.03.022 · Cited by 37
Potential Immunotargets for Alzheimer's Disease Treatment Strategies
Fernández, P. L., Britton, G. B., & Rao, K. S. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121222 · Cited by 38
Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease
Tobinick, E. L. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015073 · Cited by 34
Self-citation
Perispinal Delivery of CNS Drugs
Tobinick, E. L. (2016) · CNS Drugs · doi:10.1007/s40263-016-0339-2 · Cited by 31
Self-citation
Regulation and effects of neurotrophic factors after neural stem cell transplantation in a transgenic mouse model of Alzheimer disease
Li, B., Gao, Y., Zhang, W., & Xu, J. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24187 · Cited by 30
Cross-Talk Between Neurons and Astrocytes in Response to Bilirubin: Early Beneficial Effects
Falcão, A. S., Silva, R. F. M., Vaz, A. R., Silva, S. L., Fernandes, A. M. A., & Brites, D. M. T. O. (2013) · Neurochemical Research · doi:10.1007/s11064-012-0963-2 · Cited by 28
Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease
Nagae, T., & Araki, K. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000441 · Cited by 28
Myristica fragrans seed extract reverses scopolamine-induced cortical injury via stimulation of HO-1 expression in male rats
Al‐Quraishy, S., Dkhil, M. A., Abdel‐Gaber, R., Zrieq, R. M., Hafez, T. A., Mubaraki, M. A., & Moneim, A. E. A. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-07686-8 · Cited by 26
Mannose-Binding Lectin Binds to Amyloid Protein and Modulates Inflammation
Larvie, M., Shoup, T. M., Chang, W., Chigweshe, L., Hartshorn, K. L., White, M. R., Stahl, G. L., Elmaleh, D. R., & Takahashi, K. (2012) · BioMed Research International · doi:10.1155/2012/929803 · Cited by 26
A new Alzheimer's disease cell model using B cells to induce beta amyloid plaque formation and increase TNF alpha expression
Dezfulian, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.012 · Cited by 24
Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders
Rossi, D., Martorana, F., & Brambilla, L. (2011) · CNS Drugs · doi:10.2165/11593090-000000000-00000 · Cited by 24
The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer’s Disease
Pimentel, L. S. B., Allard, S. T. M., Carmo, S. D., Weinreb, O., Danik, M., Hanzel, C. E., Youdim, M. B. H., & Cuello, A. C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143126 · Cited by 23
The functional tumor necrosis factor-α (308A/G) polymorphism modulates attentional selection in elderly individuals
Gajewski, P. D., Hengstler, J. G., Golka, K., Falkenstein, M., & Beste, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.017 · Cited by 22
Association between high levels of inflammatory markers and cognitive outcomes at 4 years of age: The Rhea mother-child cohort study, Crete, Greece
Kyriklaki, A., Margetaki, K., Kampouri, M., Koutra, K., Bitsios, P., Chalkiadaki, G., Dermitzaki, E., Venihaki, M., Sarri, K. O., Anousaki, D., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.010 · Cited by 20
Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation
Völgyi, K., Háden, K., Kis, V., Gulyássy, P., Badics, K., Györffy, B. A., Simor, A., Szabó, Z., Janáky, T., Drahos, L., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9682-4 · Cited by 20
Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer’s Disease
Vicente, M. C., Paneghini, J. D. L., Stabile, A. M., Amorim, M. R., Silva, C. E. A., Patrone, L. G. A., Cunha, T. M., Bícego, K. C., Almeida, M. C., Carrettiero, D. C., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230151 · Cited by 21
As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer’s Disease
Guan, P.-P., Ge, T.-Q., & Wang, P. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10076-9 · Cited by 19
Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll‐like receptor 3 activation
Li, X., Cudaback, E., Keene, C. D., BREYER, R. M., & Montine, T. J. (2011) · Glia · doi:10.1002/glia.21125 · Cited by 17
Action of anti-TNF-α drugs on the progression of Alzheimer's disease: A case report
Camargo, C. H. F., Justus, F. F., Retzlaff, G., Blood, M. R. Y., & Schafranski, M. D. (2015) · Dementia & Neuropsychologia · doi:10.1590/1980-57642015dn92000015 · Cited by 17
A 3′UTR modification of the TNF-α mouse gene increases peripheral TNF-α and modulates the Alzheimer-like phenotype in 5XFAD mice
Kalovyrna, N., Apokotou, O., Boulekou, S., Paouri, E., Boutou, A., & Georgopoulos, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65378-2 · Cited by 16
Combining Select Neuropsychological Assessment with Blood-Based Biomarkers to Detect Mild Alzheimer's Disease: A Molecular Neuropsychology Approach
Edwards, M., Balldin, V. H., Hall, J. R., & O’Bryant, S. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140852 · Cited by 14
TNF and Leptin Tell Essentially the Same Story in Alzheimer's Disease
Clark, I. A., Alleva, L. M., & Vissel, B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110266 · Cited by 12
Choroid plexus tumor necrosis factor receptor 1: a new neuroinflammatory piece of the complex Alzheimer’s disease puzzle
Steeland, S., & Vandenbroucke, R. E. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.247443 · Cited by 12
Characterization of inflammatory biomarkers and candidates for diagnosis of Alzheimer’s disease
Bagyinszky, E., Youn, Y. C., An, S. S. A., & Kim, S. (2014) · BioChip Journal · doi:10.1007/s13206-014-8301-1 · Cited by 12
Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in Mice
Cantero-Téllez, A., Moreno‐Fierros, L., Gutiérrez‐Ospina, G., Santiago-Prieto, A. C., Juárez, I., Rodríguez‐Sosa, M., & Hernández, E. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04356-4 · Cited by 10
The Human Leukocyte Antigen Class III Haplotype Approach: New Insight in Alzheimer's Disease Inflammation Hypothesis
Maggioli, E., Boiocchi, C., Zorzetto, M., Sinforiani, E., Cereda, C., Ricevuti, G., & Cuccia, M. (2013) · Current Alzheimer Research · doi:10.2174/15672050113106660169 · Cited by 8
Blood‐based protein predictors of dementia severity as measured by δ: Replication across biofluids and cohorts
Royall, D. R., Bishnoi, R. J., Palmer, R. F., Initiative, A. D. N., Pavlik, V., Massman, P., Darby, E. J., Rodriguear, M., Ansari, A. K., DeToledo, J. C., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.09.002 · Cited by 8
Authors’ Reply to Whitlock: Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence
Ignatowski, T. A., Spengler, R. N., & Tobinick, E. L. (2014) · CNS Drugs · doi:10.1007/s40263-014-0212-0 · Cited by 7
Self-citation
In Silico Identification of a Potential TNF-Alpha Binder Using a Structural Similarity: A Potential Drug Repurposing Approach to the Management of Alzheimer’s Disease
Tettevi, E. J., Kuevi, D. N. O., Sumabe, B. K., Simpong, D. L., Maina, M. B., Dongdem, J. T., Osei-Atweneboana, M. Y., & Ocloo, A. (2024) · BioMed Research International · doi:10.1155/2024/9985719 · Cited by 6
Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease
Borgstedt, L., Bratke, S., Blobner, M., Pötzl, C., Ulm, B., Jungwirth, B., & Schmid, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1033729 · Cited by 6
Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach
Li, C., Yang, W., Meng, Y., Feng, L., Sun, L., Li, Z., Liu, X., & Li, M. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01270-y · Cited by 6
Aspirin ameliorates the neurotoxicity of benzo[a]pyrene in mice and HT22 cells: Possible role of miRNA-mRNA network
Zhang, J., Li, Y., Li, Y., Li, H., Cao, J., Li, X., Xia, N., Zhang, Z., Bai, J., & Zhang, Z. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113919 · Cited by 5
Brain Abscesses Complicating Acute Pneumococcal Meningitis During Etanercept Therapy
Kasirye, Y., Epperla, N., Manne, J. R. R., Bapani, S., & Garcia-Montilla, R. J. (2012) · Clinical Medicine & Research · doi:10.3121/cmr.2012.1049 · Cited by 5
Ratanasampil (Tibetan Medicine, RNSP) Reduces β-Amyloid Protein (Aβ) and Pro-Inflammatory Factor Levels and Improves Cognitive Functions in Mild-to-Moderate Alzheimer’s Disease (AD) Patients Living at High Altitude
Zhu, A., Xi, A., Li, G., Li, Y., Liao, B., Zhong, X., Zhou, J., Gu, S., Yu, M., & Yide, C. (2012) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2012.21009 · Cited by 4
Brain Delivery of Antibody-Derived Biologicals for Alzheimer’s Disease: An Updated Narrative Review
Sumbria, R. K., & Boado, R. J. (2026) · Antibodies · doi:10.3390/antib15020037 · Cited by 3
Nitric oxide signaling in Alzheimer's disease: A double-edged sword
Wasim, R. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178986 · Cited by 3
Immuno-Nanotherapeutics Approach for the Treatment and Management of Alzheimer’s Disease
Bukhary, D. M. (2024) · International Journal of Pharmacology · doi:10.3923/ijp.2024.1365.1380 · Cited by 3
Sleep-related breathing disorders
Shaw, P. J., Tafti, M., & Thorpy, M. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649469.030 · Cited by 3
The Association between Tumor Necrosis Factor-Alpha Inhibitor Use and Dementia Risk in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Chung, D., Noh, Y., Yu, Y. M., & Ah, Y. (2025) · Gerontology · doi:10.1159/000544123 · Cited by 2
Interaction between Prenatal and Postnatal Exposure to High-Fructose Corn Syrup Increases Gene Expression of Tnfa in Hippocampus of Offspring
Yamazaki, M., YAMADA, H., Munetsuna, E., Ando, Y., Kageyama, I., Sadamoto, N., Nouchi, Y., Teshigawara, A., Mizuno, G., Ishikawa, H., et al. (2023) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.69.237 · Cited by 2
Perispinal etanercept stroke trial design: PESTO and beyond
Tobinick, E. L., Ucci, D., Bermudo, K., & Asseraf, S. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2390636 · Cited by 2
Self-citation
In Search of Therapeutic Solutions for Alzheimer’s Disease
Ricardo, B., Faras, G., Leonel, E. C. R., & Jos, M. (2012) · InTech eBooks · doi:10.5772/34561 · Cited by 2
Tumor necrosis factor-alpha - potential target for neuroprotector dimebon
Alessenko, A. V., Бачурин, С. О., Владимировна, Г. С., Karatasso, Y. O., Shevtsova, E. F., & Shingarova, L. N. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166204418 · Cited by 2

Authors: Tobinick, E.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Tobinick, Edward
ORCID: Tobinick, Edward
Venue: CNS Drugs
Publisher: Springer Science and Business Media LLC
Published: 2009-09
Volume: 23
Issue: 9
Pages: 713-725
ISSN: 1172-7047 (ISSN-L)
DOI: 10.2165/11310810-000000000-00000
OpenAlex: W2053730308
Cited by: 117
References: 115
Citations by year: 2026: 2 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 9 · 2016: 5 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 11
FWCI: 1.10
Type: journal article
Language: en
Open access: closed
Locations: CNS Drugs (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: TNF-α, Alzheimer's disease, etanercept, anti-TNF therapy, gliotransmitters, synaptic dysfunction, amyloidogenesis, microvascular dysfunction, primary progressive aphasia
MeSH terms: Etanercept, Alzheimer Disease, Animals, Brain, Humans, Immunoglobulin G, Synaptic Transmission, Risk Factors, Tumor Necrosis Factor-alpha, Drug Delivery Systems, Receptors, Tumor Necrosis Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease: Rationale and Current Evidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks